Amyloid PET Centiloid

1 paper1 finding

Humans1

Associations

1

Plasma BD-p-tau217

upin humans1

1 study

Plasma BD-p-tau217 predicts amyloid PET Centiloid in humans (R2 = 0.63).
Humansacross the full cohortn = 924
Predicting continuous amyloid PET levels with CSF and plasma brain-derived p-tau217
Alzheimer's & dementia : the journal of the Alzheimer's Association1 Aug 2026

More on Plasma BD-p-tau217

Latest

7 in 12 months

medRxiv19 Aug

Amyloid-PET pipeline choice influences classification of preclinical Alzheimers disease

Preprint: cohort study of 433 peopleAmyloid PET

Alzheimer's & Dementia6 Aug

Predicting continuous amyloid PET levels with CSF and plasma brain-derived p-tau217

Cohort study of 924 peopleBiomarkers

AAIC 2025 Abstract8 Jan

Absolute risk of cognitive impairment by AD amyloid stages

Study in peopleBiomarkers

AAIC 2025 Abstract7 Jan

VeraBIND Tau test, a novel plasma assay for active tau pathology, identifies individuals with positive tau‐PET signal, regardless of amyloid status

Study in peopleBiomarkers

AAIC 2025 Abstract24 Dec

Predicting onset of Alzheimer disease symptoms with a plasma %p‐tau217 clock

Study in peopleBiomarkers

AAIC 2025 Abstract24 Dec

Association of Plasma Biomarkers of Alzheimer's Disease with Incident Tau PET Positivity

Study in peopleBiomarkers

AAIC 2025 Abstract23 Dec

Absolute risk of cognitive impairment by AD amyloid stages

Study in peopleBiomarkers